Evidence
![](https://psychiatryai.com/wp-content/uploads/2023/04/psychiatryai_com.webp)
Aliment Pharmacol Ther. 2024 May;59(10):1294-1295. doi: 10.1111/apt.17992.
NO ABSTRACT
PMID:38652769 | DOI:10.1111/apt.17992
![Google](https://www.google.com/images/branding/googlelogo/2x/googlelogo_light_color_92x30dp.png)
![Google Keep](https://www.gstatic.com/images/branding/product/1x/keep_48dp.png)
![Share on Linkedin](https://psychiatryai.com/wp-content/uploads/2023/10/linkedin-logo-png-2048-1.png)
Estimated reading time: 1 minute(s)
Latest: Psychiatryai.com #RAISR4D Evidence
![](/wp-content/uploads/2024/04/bd462cc11bcf0bd0d0d6f1d0f8b7cd04-modified-1.png)
Cool Evidence: Engaging Young People and Students in Real-World Evidence
![](/wp-content/uploads/2024/04/bd462cc11bcf0bd0d0d6f1d0f8b7cd04-modified-1.png)
Real-Time Evidence Search [Psychiatry]
![](/wp-content/uploads/2024/04/pubmed.png)
AI Research
![](/wp-content/uploads/2024/05/Il5nR_nf_400x400-modified-1.png)
Editorial: Crystalising the burden of steatotic liver disease-Authors’ reply
![](https://psychiatryai.com/wp-content/uploads/2023/04/psychiatryai_com.webp)
🌐 90 Days
AI Virtual Reality Related Evidence Matrix
Monitoring disease progression in metabolic dysfunction-associated steatotic liver disease Monitoring disease progression in metabolic dysfunction-associated steatotic liver disease Review article: Hepatic steatosis and its associations with acute and chronic liver diseases Global perspective on nonalcoholic fatty liver disease and nonalcoholic steatohepatitis - prevalence, clinical impact, economic implications and management strategies Outcomes of patients with alcohol-associated hepatitis and acute kidney injury - Results from the HRS Harmony Consortium A Comparison of Effectiveness of Attention Process Training (APT) with Parenting Management Training (PMT) in Reducing Symptoms of Attention Deficit Hyperactivity Disorder Modeling resilience to sleep disruption to study resistance to Alzheimer's disease The burden of non-alcoholic fatty liver disease in Australia: an analysis of Global Burden of Disease study from 1990 to 2019 Reply to: Frailty and ethics at the end of life: The importance of a comprehensive assessment Outcome prediction in metabolic dysfunction-associated steatotic liver disease using stain-free digital pathological assessment Reduced risk tolerance and cortical excitability following COVID-19 infection Reduced risk tolerance and cortical excitability following COVID-19 infection Editorial Perspective: Extending IPDMA methodology to drive treatment personalisation in child mental health Persons with metabolic dysfunction-associated steatotic liver disease are at increased risk of severe depression Natural product pharmacology: the British Journal of Pharmacology perspective Metabolic dysfunction-associated steatotic liver disease prevalence and risk factors in inflammatory bowel disease in tertiary center Combination of risk alleles of PNPLA3, TM6SF2, and HSD17B13 of donors can predict recurrence of steatotic liver disease after liver transplantation Reply to: "From NAFLD to MASLD: Promise and pitfalls of a new definition": EASL, AASLD and ALEH stand united to advance the field of steatotic liver disease Editorial: "What say you?" The promise and potential pitfalls of using automated and passive monitoring approaches to assess parenting behaviours from verbal and written communication Editorial: "What say you?" The promise and potential pitfalls of using automated and passive monitoring approaches to assess parenting behaviours from verbal and written communication Long-term effects of ipragliflozin and pioglitazone on metabolic dysfunction-associated steatotic liver disease in patients with type 2 diabetes: 5 year observational follow-up of a randomized, 24 week, active-controlled trial: Effect of… New nomenclature for fatty liver disease The synergistic impact of type 2 diabetes and MASLD on cardiovascular, liver, diabetes-related and cancer outcomes The synergistic impact of type 2 diabetes and MASLD on cardiovascular, liver, diabetes-related and cancer outcomes The synergistic impact of type 2 diabetes and MASLD on cardiovascular, liver, diabetes-related and cancer outcomes Immunological mechanisms in steatotic liver diseases: An overview and clinical perspectives Swept up in the tsunami: Pediatric and adolescent steatotic (fatty) liver disease Metabolic-associated fatty liver disease is less effective in predicting mortality than non-alcoholic fatty liver disease and metabolic dysfunction-associated steatotic liver disease The Transition in Terminology: From Non-alcoholic Fatty Liver Disease (NAFLD) to Metabolic Dysfunction-associated Fatty Liver Disease (MAFLD) to Metabolic-associated Steatotic Liver Disease (MASLD) Obituary: Kypros Kypri E-cigarette policies in Aotearoa (New Zealand): An Indigenous perspective Harnessing AI as an enabler for access to mental health care services Addiction Lives: Maggie Brady Stakeholders cannot simply wait for the gambling evidence-base to develop: We must all help to build it Assisted bathing of older adults with dementia Mitigating firearm risks in older adults with delirium through preventive measures Mitigating firearm risks in older adults with delirium through preventive measures Why does problem gambling in psychotic disorders pose such a challenge for comprehension? Contingency management as a maintenance intervention in the long-term treatment of substance use disorders In memoriam: Roger Guillemin, neuroendocrinologist, Nobel Prize in physiology or medicine The relationship between alcohol use disorder and suicide by means: Context dependent Physiology is all about interactions: The prolactin and growth hormone systems as exemplars Correction to "Peer contagion dynamics in the friendships of children with ADHD" Should we combine antipsychotics in patients with bipolar disorder? How far have we advanced in early intervention for bipolar disorder? ADHD medications for cognitive impairment in bipolar disorders Need for further exploring at the intersection of ADHD medications and bipolar disorder Cognitive outcomes of children and adults with sickle cell anaemia: A contemporary cohort Telemedicine experience among family caregivers of persons with dementia Commentary on Zendle and Newall: The need for direct evaluation of the UK's gambling affordability checks policy Beyond the microscope: Unveiling bacterial vaginosis with AI-powered multiomics data analysis Children with elevated wheat IgG4 antibody titer in autism spectrum disorder: Clinical presentation and findings associated with gut microbiota Children with elevated wheat IgG4 antibody titer in autism spectrum disorder: Clinical presentation and findings associated with gut microbiota Association between the skeletal muscle mass to visceral fat area ratio and metabolic dysfunction-associated fatty liver disease: A cross-sectional study of NHANES 2017-2018 Introduction to Progress and Puzzles of Cognitive Science: Introduction to a Wiley Virtual Issue Letter to the Editor concerning "Electroconvulsive therapy in the maintenance phase of psychotic unipolar depression" Menopause and bipolar disorder: Bridging research gaps and exploring postmenopause Artificial dermatitis versus artificial intelligence: Detecting etiology with Google Lens Navigating the digital age: The need for online-specific gambling marketing regulations Navigating the digital age: The need for online-specific gambling marketing regulations Commentary on Ussher et al.: Duration and magnitude of postpartum financial incentives for the maintenance of cigarette smoking abstinence Community testing practices prompt the rethinking of gold standard autism assessment Experiences of children and adolescents with attention-deficit/hyperactivity disorder taking methylphenidate Reflecting on the association between video game addiction and early-stage inhibitory control issues: Insights from Taiwan
Evidence Blueprint
Editorial: Crystalising the burden of steatotic liver disease-Authors’ reply
![](https://psychiatryai.com/wp-content/uploads/2023/04/psychiatryai_com.webp)
☊ AI-Driven Related Evidence Nodes
(recent articles with at least 5 words in title)
More Evidence
![](https://psychiatryai.com/wp-content/uploads/2023/04/psychiatryai_com.webp)
Editorial: Crystalising the burden of steatotic liver disease-Authors’ reply
🌐 365 Days
AI Virtual Reality Related Evidence Matrix
Implications of the new nomenclature of steatotic liver disease and definition of metabolic dysfunction-associated steatotic liver disease Monitoring disease progression in metabolic dysfunction-associated steatotic liver disease Monitoring disease progression in metabolic dysfunction-associated steatotic liver disease Psychedelics in treatment of postraumatic stress disorder Prevalence of at-risk MASH, MetALD and alcohol-associated steatotic liver disease in the general population Review article: Hepatic steatosis and its associations with acute and chronic liver diseases The silent burden of non-alcoholic fatty liver disease in the elderly: A global burden of disease analysis Global perspective on nonalcoholic fatty liver disease and nonalcoholic steatohepatitis - prevalence, clinical impact, economic implications and management strategies Review article: Current indications and selection criteria for early liver transplantation in severe alcohol-associated hepatitis Meta-analysis: Impact of intragastric balloon therapy on NAFLD-related parameters in patients with obesity Outcomes of patients with alcohol-associated hepatitis and acute kidney injury - Results from the HRS Harmony Consortium Meta-analysis: Efficacy and safety of fibroblast growth factor 21 analogues for the treatment of non-alcoholic steatohepatitis and non-alcoholic steatohepatitis-related fibrosis Machine learning improves the prediction of significant fibrosis in Asian patients with metabolic dysfunction-associated steatotic liver disease - The Gut and Obesity in Asia (GO-ASIA) Study Systematic review: Glycomics as diagnostic markers for hepatocellular carcinoma Open-label, clinical trial extension: Two-year safety and efficacy results of seladelpar in patients with primary biliary cholangitis MAFLD fibrosis score: Using routine measures to identify advanced fibrosis in metabolic-associated fatty liver disease First in human randomised trial of J2H-1702: A novel 11β-hydroxysteroid dehydrogenase type 1 inhibitor for non-alcoholic steatohepatitis treatment MDMA-assisted therapy for PTSD A Comparison of Effectiveness of Attention Process Training (APT) with Parenting Management Training (PMT) in Reducing Symptoms of Attention Deficit Hyperactivity Disorder Modeling resilience to sleep disruption to study resistance to Alzheimer's disease The burden of non-alcoholic fatty liver disease in Australia: an analysis of Global Burden of Disease study from 1990 to 2019 Associations of dietary sugars with liver stiffness in Latino adolescents with obesity differ on PNPLA3 and liver disease severity Reply to: Comment on: Association of sulfonylureas with the risk of dementia: A population-based cohort study Reply to: Frailty and ethics at the end of life: The importance of a comprehensive assessment Potential Mechanisms Involving in the Pathogenesis of MASLD and Targets for Pharmacotherapy. Advancements in Metabolic Associated Steatotic Liver Disease (MASLD) Research: Diagnostics, Small Molecule Developments and Future Directions Outcome prediction in metabolic dysfunction-associated steatotic liver disease using stain-free digital pathological assessment Letter regarding 'Association of thyroid function with non-alcoholic fatty liver disease in recent-onset diabetes' Reply to Ng: a closer look at late-onset psychoses for the general internist Reply to: Disease latency and new-user versus prevalent-user cohort designs: Implications for pharmacoepidemiology in dementia Reduced risk tolerance and cortical excitability following COVID-19 infection The promise of N-acetylcysteine in the treatment of obsessive-compulsive disorder Reduced risk tolerance and cortical excitability following COVID-19 infection Pharmacogenetic testing of CYP2D6, CYP2C19 and CYP2C9 in Denmark: Agreement between publicly funded genotyping tests and the subsequent phenotype classification A novel dual near-infrared fluorescent probe for bioimaging and visualization of viscosity in acute alcoholic liver injury Innovative pharmacotherapy for hepatic metabolic and chronic inflammatory diseases in China Relationship of ferritin and hepcidin with disease severity in non-alcoholic fatty liver disease patients with type 2 diabetes mellitus Editorial: Prevention is the best cure - or is it? A cautionary tale MBOAT7 in liver and extrahepatic diseases Editorial Perspective: Extending IPDMA methodology to drive treatment personalisation in child mental health Steatotic liver disease is the most important somatic determinant of quality of life in patients with obesity: A cross-sectional study Correction to "Hepatobiliary and Pancreatic: Challenges in the diagnosis of hepatic nodules in patients with alcoholic liver cirrhosis" Association of liver fibrosis with extrahepatic cancer in steatotic liver disease patients with PNPLA3 I148M GG genotype Exclusive liquor and cocktail consumption is associated with at-risk fibrosis among nonheavy alcohol users with metabolic dysfunction-associated steatotic liver disease Commentary on Booth et al.: Measuring the health burden of homelessness Liver disease mortality and hospitalisations among people with type 2 diabetes mellitus: A population-based study Persons with metabolic dysfunction-associated steatotic liver disease are at increased risk of severe depression The double roles of T cell-mediated immune response in the progression of MASLD Natural product pharmacology: the British Journal of Pharmacology perspective Metabolic dysfunction-associated steatotic liver disease prevalence and risk factors in inflammatory bowel disease in tertiary center Obituary: Travis Thompson-Editorial Combination of risk alleles of PNPLA3, TM6SF2, and HSD17B13 of donors can predict recurrence of steatotic liver disease after liver transplantation Non-alcoholic fatty liver disease, women's health and the role of the environment Epidemiology, screening, and Co-management of type 2 diabetes mellitus and Metabolic-dysfunction associated steatotic liver disease Relationship between Helicobacter pylori infection and risk of metabolic dysfunction-associated steatotic liver disease: An updated meta-analysis Reply to: "From NAFLD to MASLD: Promise and pitfalls of a new definition": EASL, AASLD and ALEH stand united to advance the field of steatotic liver disease From metabolic dysfunction-associated fatty liver disease to metabolic dysfunction-associated steatotic liver disease: Controversy and consensus Editorial: "What say you?" The promise and potential pitfalls of using automated and passive monitoring approaches to assess parenting behaviours from verbal and written communication Editorial: "What say you?" The promise and potential pitfalls of using automated and passive monitoring approaches to assess parenting behaviours from verbal and written communication Long-term effects of ipragliflozin and pioglitazone on metabolic dysfunction-associated steatotic liver disease in patients with type 2 diabetes: 5 year observational follow-up of a randomized, 24 week, active-controlled trial: Effect of… Metabolic-Associated Steatotic Liver Disease (MASLD): A New Term for a More Appropriate Therapy in Pediatrics? New nomenclature for fatty liver disease Erythropoietin hyporesponsiveness in non-alcoholic fatty liver disease Therapeutic management of metabolic dysfunction associated steatotic liver disease Mortality in metabolic dysfunction-associated steatotic liver disease: A nationwide population-based cohort study